<HashMap><database>MetabolomicsWorkbench</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>http://www.metabolomicsworkbench.org/rest/study/study_id/ST000682/mwtab</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Metabolomics</omics_type><technology_type>Mass Spectrometry</technology_type><technology_type>ESI</technology_type><species>Mus Musculus</species><full_dataset_link>http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&amp;StudyID=ST000682</full_dataset_link><study_factor>CRE:Rod Cre | SEX:f</study_factor><study_factor>CRE:Cone Cre | SEX:m</study_factor><study_factor>CRE:negative | SEX:m</study_factor><study_factor>CRE:Cone Cre | SEX:f</study_factor><study_factor>CRE:negative | SEX:f</study_factor><submitter_affiliation>University of Michigan</submitter_affiliation><tissue>Eye Tissue</tissue><sample_protocol>C18 NEGATIVE ION MODE. C18 POSITIVE ION MODE.</sample_protocol><repository>MetabolomicsWorkbench</repository><metabolite_name>SM 40:2; [M]+@7.27</metabolite_name><metabolite_name>PC 18:0; [M+Na]+@1.93</metabolite_name><metabolite_name>TG 58:7; [M+NH4]+@10.52</metabolite_name><metabolite_name>TG 52:6; [M+Na]+@9.83</metabolite_name><metabolite_name>FFA(18:0)</metabolite_name><metabolite_name>DG 36:1; [M+NH4]+@8.47</metabolite_name><metabolite_name>PG 44:11; [M-H]-@4.73</metabolite_name><metabolite_name>SM 44:2; [M+Na]+@8.32</metabolite_name><metabolite_name>plasmenyl-PE 38:3; [M-H]-@7.49</metabolite_name><metabolite_name>FFA(24:0)</metabolite_name><metabolite_name>TG 48:0; [M+NH4]+@10.57</metabolite_name><metabolite_name>PE 35:0; [M-H]-@7.49</metabolite_name><metabolite_name>plasmenyl-PC 34:1; [M+Na]+@7.17</metabolite_name><metabolite_name>SM 33:1; [M+Na]+@5.55</metabolite_name><metabolite_name>lysoPE 18:0; [M-H]-@2.44</metabolite_name><metabolite_name>PC 44:12; [M-Ac-H]-@5.51</metabolite_name><metabolite_name>PE 36:6; [M-H]-@5.37</metabolite_name><metabolite_name>TG 54:6; [M+NH4]+@10.22</metabolite_name><metabolite_name>FFA(20:4) Arachidonic acid</metabolite_name><metabolite_name>plasmenyl-PE 38:4; [M+H]+@7.24</metabolite_name><metabolite_name>PC 42:10; [M-Ac-H]-@5.66</metabolite_name><metabolite_name>TG 62:14; [M+NH4]+@9.83</metabolite_name><metabolite_name>FFA(18:1)</metabolite_name><metabolite_name>PG 36:2; [M-H]-@5.94</metabolite_name><metabolite_name>lysoPE 16:0; [M+H]+@1.69</metabolite_name><metabolite_name>PC 35:1; [M-Ac-H]-@6.95</metabolite_name><metabolite_name>TG 62:12; [M+NH4]+@10.21</metabolite_name><metabolite_name>PI 38:4; [M-H]-@5.85</metabolite_name><metabolite_name>PC 40:4; [M-Ac-H]-@7.23</metabolite_name><metabolite_name>PC 50:6; [M+Na]+@9.07</metabolite_name><metabolite_name>SM 37:2; [M]+@6.44</metabolite_name><metabolite_name>DG 44:12; [M+NH4]+@6.99</metabolite_name><metabolite_name>lysoPE 22:6; [M+H]+@1.29</metabolite_name><metabolite_name>SM 35:2; [M]+@5.76</metabolite_name><metabolite_name>PS 38:6; [M-H]-@5.21</metabolite_name><metabolite_name>PE 42:6; [M+H]+@7.49</metabolite_name><metabolite_name>TG 50:0; [M+NH4]+@10.79</metabolite_name><metabolite_name>PC 36:3; [M-Ac-H]-@6.39</metabolite_name><metabolite_name>CL 72:5; [M-2H](2-)@9.47</metabolite_name><metabolite_name>lysoPC 16:0; [M+H]+@1.80</metabolite_name><metabolite_name>TG 50:2; [M+NH4]+@10.37</metabolite_name><metabolite_name>SM 41:2; [M]+@7.72</metabolite_name><metabolite_name>PE 34:2; [M+H]+@6.43</metabolite_name><metabolite_name>TG 53:0; [M+NH4]+@11.15</metabolite_name><metabolite_name>PE 34:1; [M+H]+@6.85</metabolite_name><metabolite_name>PE 36:0; [M+H]+@7.91</metabolite_name><metabolite_name>PA 42:9; [M+Na]+@4.71</metabolite_name><metabolite_name>TG 54:4; [M+NH4]+@10.45</metabolite_name><metabolite_name>PE 35:1; [M+H]+@7.17</metabolite_name><metabolite_name>TG 60:10; [M+NH4]+@10.30</metabolite_name><metabolite_name>plasmenyl-PE 42:6; [M+H]+@7.79</metabolite_name><metabolite_name>PS 40:4; [M-H]-@6.42</metabolite_name><metabolite_name>TG 48:2; [M+NH4]+@10.14</metabolite_name><metabolite_name>PC 38:1; [M-Ac-H]-@7.74</metabolite_name><metabolite_name>TG 50:3; [M+NH4]+@10.16</metabolite_name><metabolite_name>PS 40:5; [M+Na]+@6.07</metabolite_name><metabolite_name>TG 40:0; [M+NH4]+@9.47</metabolite_name><metabolite_name>PC 33:0; [M-Ac-H]-@6.80</metabolite_name><metabolite_name>PE 44:12; [M-H]-@5.63</metabolite_name><metabolite_name>PC 31:0; [M-Ac-H]-@6.20</metabolite_name><metabolite_name>plasmenyl-PE 34:0; [M-H]-@7.40</metabolite_name><metabolite_name>PC 34:2; [M-Ac-H]-@6.17</metabolite_name><metabolite_name>PG 42:10; [M-H]-@4.64</metabolite_name><metabolite_name>PS 40:6; [M-H]-@5.88</metabolite_name><metabolite_name>PC 36:1; [M-Ac-H]-@7.15</metabolite_name><metabolite_name>PE 40:7; [M+H]+@6.40</metabolite_name><metabolite_name>TG 54:3; [M+NH4]+@10.66</metabolite_name><metabolite_name>FFA(22:2)</metabolite_name><metabolite_name>PE 40:8; [M+H]+@5.96</metabolite_name><metabolite_name>SM 42:2; [M+Na]+@7.85</metabolite_name><metabolite_name>PC 40:9; [M+Na]+@5.44</metabolite_name><metabolite_name>DG 34:0; [M+NH4]+@8.41</metabolite_name><metabolite_name>PG 44:12; [M-H]-@4.49</metabolite_name><metabolite_name>plasmenyl-PE 32:0; [M-H]-@7.02</metabolite_name><metabolite_name>PS 42:10; [M-H]-@4.78</metabolite_name><metabolite_name>SM 37:1; [M]+@6.90</metabolite_name><metabolite_name>DG 37:4; [M+NH4]+@7.84</metabolite_name><metabolite_name>TG 58:10; [M+NH4]+@10.10</metabolite_name><metabolite_name>PC 38:3; [M-Ac-H]-@7.04</metabolite_name><metabolite_name>SM 36:1; [M]+@6.55</metabolite_name><metabolite_name>DG 38:4; [M+NH4]+@8.02</metabolite_name><metabolite_name>PC 39:6; [M-Ac-H]-@6.40</metabolite_name><metabolite_name>PG 34:1; [M-H]-@5.82</metabolite_name><metabolite_name>PE 37:4; [M-H]-@6.63</metabolite_name><metabolite_name>DG 40:6; [M+NH4]+@7.97</metabolite_name><metabolite_name>SM 34:2; [M+Na]+@5.44</metabolite_name><metabolite_name>lysoPE 18:1; [M+H]+@1.84</metabolite_name><metabolite_name>FFA(22:3)</metabolite_name><metabolite_name>plasmenyl-PE 36:3; [M+H]+@6.94</metabolite_name><metabolite_name>PC 32:1; [M-Ac-H]-@6.00</metabolite_name><metabolite_name>PC 36:4; [M-Ac-H]-@6.15</metabolite_name><metabolite_name>PS 36:4; [M-H]-@5.31</metabolite_name><metabolite_name>DG 42:10; [M+NH4]+@7.07</metabolite_name><metabolite_name>plasmenyl-PE 38:1; [M+H]+@8.25</metabolite_name><metabolite_name>TG 48:3; [M+NH4]+@9.89</metabolite_name><metabolite_name>DG 38:5; [M+NH4]+@7.67</metabolite_name><metabolite_name>PG 38:4; [M-H]-@6.01</metabolite_name><metabolite_name>TG 52:1; [M+NH4]+@10.79</metabolite_name><metabolite_name>FFA(16:0)</metabolite_name><metabolite_name>PG 36:3; [M-H]-@5.62</metabolite_name><metabolite_name>lysoPE 18:0; [M+H]+@2.48</metabolite_name><metabolite_name>PE 38:4; [M+H]+@7.03</metabolite_name><metabolite_name>PE 38:1; [M-H]-@7.83</metabolite_name><metabolite_name>PE 38:5; [M+H]+@6.52</metabolite_name><metabolite_name>lysoPC 22:6; [M+H]+@1.42</metabolite_name><metabolite_name>TG 56:4; [M+NH4]+@10.82</metabolite_name><metabolite_name>PC 38:2; [M-Ac-H]-@7.30</metabolite_name><metabolite_name>FFA(22:0)</metabolite_name><metabolite_name>DG 36:0; [M+NH4]+@8.88</metabolite_name><metabolite_name>MG 17:0; [M+Li]+@3.16</metabolite_name><metabolite_name>PC 36:0; [M-Ac-H]-@7.66</metabolite_name><metabolite_name>PS 34:2; [M-H]-@5.30</metabolite_name><metabolite_name>PS 42:7; [M-H]-@5.97</metabolite_name><metabolite_name>DG 36:2; [M+NH4]+@8.09</metabolite_name><metabolite_name>PE 38:3; [M-H]-@7.19</metabolite_name><metabolite_name>DG 36:3; [M+NH4]+@7.79</metabolite_name><metabolite_name>TG 54:7; [M+NH4]+@10.04</metabolite_name><metabolite_name>PG 36:5; [M-H]-@5.03</metabolite_name><metabolite_name>SM 42:4; [M]+@6.95</metabolite_name><metabolite_name>TG 66:18; [M+NH4]+@9.69</metabolite_name><metabolite_name>plasmenyl-PC 18:0; [M+Na]+@1.66</metabolite_name><metabolite_name>PC 42:6; [M-Ac-H]-@7.31</metabolite_name><metabolite_name>plasmenyl-PE 40:6; [M+H]+@7.20</metabolite_name><metabolite_name>PS 42:9; [M-H]-@5.05</metabolite_name><metabolite_name>PS 44:12; [M-H]-@4.67</metabolite_name><metabolite_name>FFA(22:1)</metabolite_name><metabolite_name>PE 40:5; [M-H]-@7.04</metabolite_name><metabolite_name>PG 36:0; [M-H]-@6.89</metabolite_name><metabolite_name>PE 42:7; [M-H]-@6.92</metabolite_name><metabolite_name>PE 32:1; [M+H]+@6.25</metabolite_name><metabolite_name>SM 42:1; [M+Na]+@8.33</metabolite_name><metabolite_name>PE 37:6; [M+H]+@6.02</metabolite_name><metabolite_name>TG 48:1; [M+NH4]+@10.36</metabolite_name><metabolite_name>plasmenyl-PE 36:5; [M+H]+@6.32</metabolite_name><metabolite_name>PC 28:0; [M-Ac-H]-@5.19</metabolite_name><metabolite_name>PE 44:10; [M-H]-@6.30</metabolite_name><metabolite_name>PE 21:4; [M+H]+@1.46</metabolite_name><metabolite_name>PC 38:4; [M+H]+@8.51</metabolite_name><metabolite_name>plasmenyl-PE 40:5; [M+H]+@7.34</metabolite_name><metabolite_name>PC 40:7; [M+H]+@6.97</metabolite_name><metabolite_name>TG 58:6; [M+NH4]+@10.77</metabolite_name><metabolite_name>CL 72:4; [M-2H](2-)@9.62</metabolite_name><metabolite_name>PS 38:4; [M-H]-@5.93</metabolite_name><metabolite_name>SM 30:1; [M]+@4.42</metabolite_name><metabolite_name>PE 32:0; [M-H]-@6.67</metabolite_name><metabolite_name>PE 42:8; [M+H]+@6.55</metabolite_name><metabolite_name>plasmenyl-PE 36:1; [M+H]+@7.75</metabolite_name><metabolite_name>PE 36:5; [M-H]-@5.88</metabolite_name><metabolite_name>plasmenyl-PE 40:4; [M-H]-@7.62</metabolite_name><metabolite_name>plasmenyl-PC 32:0; [M+Na]+@7.03</metabolite_name><metabolite_name>SM 34:1; [M]+@5.86</metabolite_name><metabolite_name>PE 40:9; [M-H]-@5.49</metabolite_name><metabolite_name>PC 33:1; [M-Ac-H]-@6.36</metabolite_name><metabolite_name>TG 58:8; [M+NH4]+@10.37</metabolite_name><metabolite_name>PG 32:0; [M-H]-@5.77</metabolite_name><metabolite_name>PS 44:11; [M-H]-@4.88</metabolite_name><metabolite_name>CL 74:7; [M-2H](2-)@6.02</metabolite_name><metabolite_name>PI 36:4; [M-H]-@5.22</metabolite_name><metabolite_name>plasmenyl-PE 34:1; [M-H]-@7.06</metabolite_name><metabolite_name>PC 42:7; [M+H]+@6.71</metabolite_name><metabolite_name>PC 38:6; [M-Ac-H]-@5.98</metabolite_name><metabolite_name>N-(hexadecanoyl)-sphing-4-enine; [M-H]-@6.80</metabolite_name><metabolite_name>PG 38:5; [M-H]-@5.54</metabolite_name><metabolite_name>PE 36:1; [M+H]+@7.46</metabolite_name><metabolite_name>PC 40:10; [M+H]+@5.56</metabolite_name><metabolite_name>FFA(20:2)</metabolite_name><metabolite_name>TG 49:1; [M+NH4]+@10.45</metabolite_name><metabolite_name>N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.37</metabolite_name><metabolite_name>plasmenyl-PE 36:0; [M+H]+@8.22</metabolite_name><metabolite_name>TG 56:8; [M+NH4]+@10.09</metabolite_name><metabolite_name>PS 34:1; [M-H]-@5.99</metabolite_name><metabolite_name>PC 48:6; [M+Na]+@8.55</metabolite_name><metabolite_name>TG 52:2; [M+NH4]+@10.60</metabolite_name><metabolite_name>TG 54:1; [M+NH4]+@11.05</metabolite_name><metabolite_name>plasmenyl-PE 34:2; [M-H]-@6.65</metabolite_name><metabolite_name>PC 34:3; [M+H]+@6.62</metabolite_name><metabolite_name>TG 52:4; [M+NH4]+@10.21</metabolite_name><metabolite_name>PE 42:9; [M-H]-@6.06</metabolite_name><metabolite_name>PS 40:7; [M-H]-@5.32</metabolite_name><metabolite_name>PE 34:3; [M-H]-@5.99</metabolite_name><metabolite_name>PC 42:11; [M+H]+@5.82</metabolite_name><metabolite_name>TG 56:7; [M+NH4]+@10.27</metabolite_name><metabolite_name>TG 46:0; [M+NH4]+@10.35</metabolite_name><metabolite_name>SM 36:2; [M]+@6.01</metabolite_name><metabolite_name>PC 32:0; [M+H]+@6.61</metabolite_name><metabolite_name>PC 40:8; [M+Na]+@5.82</metabolite_name><metabolite_name>plasmenyl-PE 38:2; [M-H]-@7.75</metabolite_name><metabolite_name>PG 40:6; [M-H]-@5.95</metabolite_name><metabolite_name>TG 56:6; [M+NH4]+@10.54</metabolite_name><metabolite_name>PE 38:7; [M+H]+@5.63</metabolite_name><metabolite_name>SM 40:1; [M+Na]+@7.86</metabolite_name><metabolite_name>PC 34:4; [M+H]+@6.14</metabolite_name><metabolite_name>PC 34:1; [M-Ac-H]-@6.56</metabolite_name><metabolite_name>FFA(20:0)</metabolite_name><metabolite_name>lysoPC 19:0; [M+H]+@2.95</metabolite_name><metabolite_name>TG 60:12; [M+NH4]+@9.99</metabolite_name><metabolite_name>PE 38:2; [M-H]-@7.46</metabolite_name><metabolite_name>DG 40:7; [M+NH4]+@7.54</metabolite_name><metabolite_name>TG 50:4; [M+NH4]+@9.95</metabolite_name><metabolite_name>plasmenyl-PE 38:6; [M+H]+@6.58</metabolite_name><metabolite_name>PC 38:5; [M+Na]+@6.46</metabolite_name><metabolite_name>PS 42:11; [M-H]-@4.37</metabolite_name><metabolite_name>DG 38:3; [M+NH4]+@8.31</metabolite_name><metabolite_name>PC 30:1; [M-Ac-H]-@5.41</metabolite_name><metabolite_name>PG 34:2; [M-H]-@5.42</metabolite_name><metabolite_name>plasmenyl-PE 36:2; [M-H]-@7.24</metabolite_name><metabolite_name>PE 36:4; [M+H]+@6.34</metabolite_name><metabolite_name>DG 38:6; [M+NH4]+@7.47</metabolite_name><metabolite_name>PC 38:7; [M-Ac-H]-@5.59</metabolite_name><metabolite_name>FFA(20:1)</metabolite_name><metabolite_name>TG 58:9; [M+NH4]+@10.18</metabolite_name><metabolite_name>PC 40:6; [M-Ac-H]-@6.65</metabolite_name><metabolite_name>PG 40:7; [M-H]-@5.16</metabolite_name><metabolite_name>PG 40:8; [M-H]-@4.64</metabolite_name><metabolite_name>TG 54:5; [M+NH4]+@10.36</metabolite_name><metabolite_name>PE 40:6; [M+H]+@6.87</metabolite_name><metabolite_name>lysoPE 20:4; [M+H]+@1.37</metabolite_name><metabolite_name>PG 38:6; [M-H]-@5.34</metabolite_name><metabolite_name>FFA(18:2)</metabolite_name><metabolite_name>PG 36:4; [M-H]-@5.41</metabolite_name><metabolite_name>FFA(24:2)</metabolite_name><metabolite_name>DG 36:4; [M+NH4]+@7.57</metabolite_name><metabolite_name>PC 36:2; [M-Ac-H]-@6.72</metabolite_name><metabolite_name>PE 40:4; [M-H]-@7.33</metabolite_name><metabolite_name>plasmenyl-PE 32:1; [M+H]+@6.62</metabolite_name><metabolite_name>plasmenyl-PE 36:4; [M+H]+@6.69</metabolite_name><metabolite_name>PE 36:3; [M-H]-@6.46</metabolite_name><metabolite_name>PC 40:5; [M-Ac-H]-@6.91</metabolite_name><metabolite_name>TG 52:0; [M+NH4]+@11.01</metabolite_name><metabolite_name>plasmenyl-PE 38:5; [M+H]+@7.02</metabolite_name><metabolite_name>SM 38:1; [M]+@7.17</metabolite_name><metabolite_name>PC 30:0; [M-Ac-H]-@5.85</metabolite_name><metabolite_name>PC 36:6; [M-Ac-H]-@5.40</metabolite_name><metabolite_name>PE 41:6; [M-H]-@7.15</metabolite_name><metabolite_name>PE 36:2; [M+H]+@6.99</metabolite_name><metabolite_name>PS 44:10; [M-H]-@5.32</metabolite_name><metabolite_name>TG 50:1; [M+NH4]+@10.57</metabolite_name><metabolite_name>PE 38:6; [M+H]+@6.26</metabolite_name><metabolite_name>SM 41:1; [M]+@8.08</metabolite_name><metabolite_name>lysoPC 20:3; [M+Na]+@1.47</metabolite_name><metabolite_name>TG 46:1; [M+NH4]+@10.12</metabolite_name><metabolite_name>DG 32:0; [M+NH4]+@7.89</metabolite_name><metabolite_name>TG 52:3; [M+NH4]+@10.40</metabolite_name><metabolite_name>PC 42:8; [M-Ac-H]-@6.34</metabolite_name><data_protocol></data_protocol><name_synonyms>study, Lyzs, Lzp, (3beta, AI326280., Vitamin A Aldehyde, Vitamin A, Tissue, Cholest-5-en-3beta-ol, Retinyl, Retinene, Epicholesterol, 6-trimethyl-1-cyclohexen-1-yl)-2, Retinyl Aldehydde, 11 cis Retinal, Lysm, Axerophthal, all-trans-Retinal, 7-dimethyl-9-(2, Lys, 11-trans-Retinal, Cholest-5-en-3-ol (3beta)-, all trans Retinal, Aldehyde, efflux, Aldehydde, 17alpha)-cholest-5-en-3-ol, 3, 4, simple tissue, 11-cis-Retinal, Lzm-s1, 6, Cholesterin, 14beta, 8-Nonatetraenal, Retinal, 11 trans Retinal, Lzm</name_synonyms><sample_synonyms>C18, D1, PTHB1, B1, B1.</sample_synonyms></additional><is_claimable>false</is_claimable><name>Retinal tissue knockout to study efflux of cholesterol (AGCA1/G1 double KO - TY and LysM cre) - part II</name><description/><dates><publication></publication></dates><accession>ST000682</accession><cross_references><TAXONOMY>10090</TAXONOMY></cross_references></HashMap>